ReviewHeliyon2024
Rationale for immune checkpoint inhibitors plus targeted therapy for advanced renal cell carcinoma.
Siwei Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewHeliyon2024
Siwei Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.